A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors Including DIPG
Condition(s):Pediatric Brain Tumor; Diffuse Intrinsic Pontine GliomaLast Updated:November 11, 2021Terminated
Hide Studies Not Open or Pending
Condition(s):Pediatric Brain Tumor; Diffuse Intrinsic Pontine GliomaLast Updated:November 11, 2021Terminated
Condition(s):Childhood Brain TumorLast Updated:August 24, 2017Terminated
Condition(s):Childhood Brain TumorsLast Updated:March 7, 2022Completed
Condition(s):Childhood Brain TumorLast Updated:January 26, 2024Completed
Condition(s):Childhood Brain TumorLast Updated:July 18, 2023Suspended
Condition(s):Recurrent Childhood Brain TumorLast Updated:December 15, 2016Unknown status
Condition(s):Pediatric Brain TumorLast Updated:January 26, 2024Recruiting
Condition(s):Brain NeoplasmLast Updated:July 21, 2017Unknown status
Condition(s):Pediatric Brain TumorLast Updated:September 24, 2019Withdrawn
Condition(s):Pediatric Brain TumorLast Updated:May 25, 2021Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.